Specialty medications are some of the most expensive drugs on the market. While they comprise a small percentage of prescriptions filled every year, they account for approximately half the country’s annual drug spending and continue to outpace growth in the rest of the market.[1] These costs have consistently risen for more than a decade. From 2011-2016, specialty medication spending increased by $54 billion.[2]
Rising costs jeopardize care for specialty patients. Unaffordable healthcare costs impact an estimated 1 in 4 Americans, and 1 in 3 delay care due to financial strain.[4] Even patients covered under private insurance or Medicare may struggle to cover their out-of-pocket expenses. When critical medications are unaffordable, the entire healthcare system experiences negative impacts:
CPS® technology tackles this problem head-on with a comprehensive tool for specialty pharmacies. The TherigySTM® Financial Assistance Tool allows specialty pharmacies to track drug eligibility, funding and provides a real-time integration with 501c(3) Foundations to proactively alert staff when funds become available. This innovative tool enables users to proactively manage healthcare costs in many ways:
To learn more about the TherigySTM Financial Assistance Tool, schedule a demo with a member of our team today!
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365501/
[2] https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/medicines-use-and-spending-shifts-in-the-us-in-2014.pdf
[3] https://press.aarp.org/2021-9-28-Average-Specialty-Drug-Price-Reached-84,442-2020-Rising-Three-Times-Faster-Prices-Other-Goods-Services
[4] https://www.healthsystemtracker.org/chart-collection/cost-affect-access-care/